Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NeuroDawn Pharmaceutical

Request full access

Developing novel drugs for central nervous system diseases

Nanjing City, ChinaFounded 2020

About NeuroDawn Pharmaceutical

NeuroDawn Pharmaceutical is a privately held biotechnology company founded in 2020 and based in Nanjing, China. The company focuses on the research and development of new drugs, particularly multi-acting new chemical entities and novel combinations, for treating central nervous system (CNS) diseases. It operates with an integrated internal R&D platform that encompasses chemical synthesis, biological screening, chemistry, manufacturing, and control (CMC) development, drug metabolism and pharmacokinetics (DMPK) research, and clinical research.

The company's pipeline includes treatments for conditions like acute ischemic stroke. One of its key products is the Y-3 injection, a Class 1 innovative drug designed to alleviate neurological symptoms and improve daily activities for patients with acute ischemic stroke. In August 2023, NeuroDawn entered into a collaboration agreement with China Medical System Holdings Limited, granting them exclusive promotion rights for the Y-3 injection in Mainland China, Hong Kong, and Macao.

NeuroDawn Pharmaceutical has secured significant funding, raising $53.7 million from investors including Jiangning Kechuang Group, Chunxin Capital, Fujian Huaxing Venture Capital, Red Horse Investment Group, and Tencent Investment. The company employs around 100 people and serves hospitals by providing effective treatment options for patients with neurological diseases.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
14.0/100
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Nov 2023 $0 — Tencent ↗
SERIES AEquity / VC Feb 2023 $14M $55M Simcere Pharma · China Merchants Health ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

NeuroDawn Pharmaceutical website traffic

Latest recorded traffic for NeuroDawn Pharmaceutical is 840 monthly website visits, up 8300% over the last three months.

Latest monthly visits840 3-month web change+8300%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

NeuroDawn Pharmaceutical in the Nanjing City ecosystem

Live from Dealroom

The NeuroDawn Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Dynamic Balance Capital
  • Nanjing Industrial Development Fund
  • Shanghai Haoyuan Biotech
  • Simcere Pharma
  • China Merchants Health
  • Tencent
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Nanjing City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NeuroDawn Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NeuroDawn Pharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.